Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Leases Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Growth Metrics

CV Sciences (CVSI) Convertible Debt (2016 - 2022)

CV Sciences' Convertible Debt history spans 5 years, with the latest figure at $2.1 million for Q4 2022.

On a quarterly basis, Convertible Debt rose 100.0% to $2.1 million in Q4 2022 year-over-year; TTM through Dec 2022 was $2.1 million, a 100.0% increase, with the full-year FY2022 number at $2.1 million, up 100.0% from a year prior.
Convertible Debt hit $2.1 million in Q4 2022 for CV Sciences, roughly flat from $2.1 million in the prior quarter.
Over the last five years, Convertible Debt for CVSI hit a ceiling of $2.1 million in Q1 2022 and a floor of $1.1 million in Q4 2021.